The Efficacy of Interferential Current Treatment on Knee Osteoarthritis
NCT ID: NCT04015323
Last Updated: 2020-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2019-07-01
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interferential Current Therapy After Total Knee Arthroplasty
NCT03542981
Comparison of Effectiveness of Two Different Electrotherapy Agents on Central Sensitization
NCT04153825
Intra-articular Viscosupplement Application in Knee Osteoarthritis
NCT03913052
r-ESWT in Moderate Knee Osteoarthritis
NCT04243135
Neuromuscular Electrical Stimulation and Ultrasound Therapies , Knee Osteoarthritis
NCT03727256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IFC Therapy 2 kHz Arm
Subjects in this group will receive interferential current to their knees with a carrier frequency of 2 kHz
Interferential current
An electrotherapy current with different carrier frequencies
IFC Therapy 4 kHz Arm
Subjects in this group will receive interferential current to their knees with a carrier frequency of 4 kHz
Interferential current
An electrotherapy current with different carrier frequencies
IFC Therapy 8 kHz Arm
Subjects in this group will receive interferential current to their knees with a carrier frequency of 8 kHz
Interferential current
An electrotherapy current with different carrier frequencies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interferential current
An electrotherapy current with different carrier frequencies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Knee VAS pain scores ≥ 4
* Kellgren-Lawrence radiologic scores 2 and 3
Exclusion Criteria
* Inflammatory arthritis
* Paralysis of lower extremities
* Serious cardiovascular disease /presence of cardiac pacemaker
* Severe osteoarhthritis of lower extremity joints other than the knees
* History of newly diagnosed cancer (ın the last 6 months)
* Cognitive impairment
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benil Nesli Ata, MD
Principal Inversitagor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benil N Ata, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ege University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University School of Medicine
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-5.1/24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.